A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma
Ashley Cimino‐Mathews(Bloomberg (United States)), Roisín M. Connolly(Johns Hopkins University), Sangita Verma, Maria Cristina Figueroa Magalhães(Johns Hopkins University), Vered Stearns(Johns Hopkins University), Zhe Zhang(Peking University), Stacie C. Jeter(Johns Hopkins University), Pedram Argani(Johns Hopkins University)
Cited by 100
Related Papers
CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment
|JNCI Journal of the National Cancer Institute|2005|947
Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine
|JNCI Journal of the National Cancer Institute|2003|850
American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer
|Journal of Clinical Oncology|2010|800
Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
|Journal of Clinical Oncology|2014|795
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751